KalVista Pharmaceuticals Inc. (KALV) NASDAQ
$11.57 0.07 (0.61%)
Market Cap: $488.12M
As of 04/19/24 04:00 PM EDT. Market closed.
KalVista Pharmaceuticals Inc. (KALV)
NASDAQ
$11.57
0.07 (0.61%)
Market Cap: $488.12M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease ... read more
kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Thomas Crockett
Full Time Employees
95
CEO Compensation (Base)
$505,000
CEO Compensation (Total)
$3.29M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Thomas Crockett
Full Time Employees
95
CEO Compensation (Base)
$505,000
CEO Compensation (Total)
$3.29M
URL
Address
55 Cambridge Pkwy Ste 901E, Massachusetts, Cambridge, 02142-1234.
PRICE CHART FOR KALVISTA PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$11.46
Previous Close
$11.50
Days Range
$11.28 - $11.73
52 week range
$7.21 - $16.88
Volume
346,978
Avg. Volume (30 days)
534,265
Market Cap
$488.12M
Dividend Yield
-
P/E
(12.89)
Shares Outstanding
42,188,296
Open
$11.46
Previous Close
$11.50
Days Range
$11.28 - $11.73
52 week range
$7.21 - $16.88
Volume
346,978
Avg. Volume (30 days)
534,265
Market Cap
$488.12M
Dividend Yield
-
P/E
(12.89)
Shares Outstanding
42,188,296
FINANCIAL STATEMENTS FOR KALVISTA PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR KALVISTA PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Feener Edward P. | CHIEF SCIENTIFIC OFFICER | Feb 20, 2024 | Sale | $14.07 | 28,288 | 397,929 | 82,048 | Feb 21, 2024, 09:51 PM |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Feb 20, 2024 | Sale | $14.11 | 12,053 | 170,124 | 72,895 | Feb 21, 2024, 09:48 PM |
| Palleiko Benjamin L | CFO, CBO | Feb 20, 2024 | Sale | $14.11 | 22,802 | 321,846 | 187,315 | Feb 21, 2024, 09:46 PM |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Feb 20, 2024 | Sale | $14.11 | 14,295 | 201,774 | 52,886 | Feb 21, 2024, 09:44 PM |
| Crockett Thomas Andrew | CEO | Feb 20, 2024 | Sale | $14.11 | 24,888 | 351,289 | 211,203 | Feb 21, 2024, 09:41 PM |
| Palleiko Benjamin L | CFO, CBO | Feb 14, 2024 | Sale | $15.01 | 40,855 | 613,205 | 159,088 | Feb 16, 2024, 04:21 PM |
| Crockett Thomas Andrew | CEO | Feb 14, 2024 | Sale | $15.01 | 58,356 | 875,883 | 181,676 | Feb 16, 2024, 04:20 PM |
| Feener Edward P. | CHIEF SCIENTIFIC OFFICER | Feb 14, 2024 | Sale | $15.01 | 28,171 | 422,827 | 71,657 | Feb 16, 2024, 04:19 PM |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Feb 14, 2024 | Sale | $15.01 | 39,886 | 598,661 | 66,160 | Feb 16, 2024, 04:18 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Feb 08, 2024 | Buy | $14.70 | 29,747 | 437,281 | 4,824,731 | Feb 08, 2024, 08:11 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Feb 07, 2024 | Buy | $14.56 | 51,827 | 754,601 | 4,794,984 | Feb 08, 2024, 08:11 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Feb 06, 2024 | Buy | $14.74 | 4,474 | 65,947 | 4,743,157 | Feb 08, 2024, 08:11 PM |
| Crockett Thomas Andrew | CEO | Feb 01, 2024 | Sale | $16.22 | 10,000 | 162,198 | 118,232 | Feb 05, 2024, 05:55 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 30, 2024 | Buy | $14.47 | 88,099 | 1,274,793 | 4,738,683 | Feb 01, 2024, 04:38 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 29, 2024 | Buy | $14.22 | 80,600 | 1,146,132 | 4,650,584 | Jan 29, 2024, 07:07 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 26, 2024 | Buy | $12.98 | 4,174 | 54,179 | 4,569,984 | Jan 29, 2024, 07:07 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 25, 2024 | Buy | $12.73 | 7,030 | 89,492 | 4,565,810 | Jan 29, 2024, 07:07 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 23, 2024 | Buy | $12.54 | 10,897 | 136,648 | 4,538,094 | Jan 24, 2024, 08:24 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 22, 2024 | Buy | $12.55 | 67,546 | 847,702 | 4,527,197 | Jan 24, 2024, 08:24 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 24, 2024 | Buy | $12.44 | 20,686 | 257,334 | 4,558,780 | Jan 24, 2024, 08:24 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 19, 2024 | Buy | $12.43 | 25,000 | 310,750 | 4,459,651 | Jan 19, 2024, 06:02 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 18, 2024 | Buy | $12.51 | 39,680 | 496,397 | 4,434,651 | Jan 19, 2024, 06:02 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 17, 2024 | Buy | $12.60 | 78,925 | 994,455 | 4,394,971 | Jan 19, 2024, 06:02 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 11, 2024 | Buy | $12.68 | 6,647 | 84,284 | 4,296,447 | Jan 16, 2024, 07:04 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 16, 2024 | Buy | $12.73 | 19,599 | 249,495 | 4,316,046 | Jan 16, 2024, 07:04 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 11, 2024 | Sale | $13.03 | 22,679 | 295,514 | 39,828 | Jan 12, 2024, 04:26 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 10, 2024 | Buy | $12.67 | 47,700 | 604,359 | 4,289,800 | Jan 10, 2024, 08:57 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 09, 2024 | Buy | $12.56 | 20,816 | 261,449 | 4,242,100 | Jan 10, 2024, 08:57 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 08, 2024 | Buy | $12.44 | 69,184 | 860,649 | 4,221,284 | Jan 10, 2024, 08:57 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 09, 2024 | Sale | $13.00 | 100 | 1,300 | 62,507 | Jan 10, 2024, 06:05 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 08, 2024 | Sale | $13.01 | 17,221 | 224,000 | 62,607 | Jan 10, 2024, 06:05 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 03, 2024 | Buy | $12.20 | 17,605 | 214,781 | 4,110,336 | Jan 05, 2024, 04:13 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Jan 04, 2024 | Buy | $12.11 | 41,764 | 505,762 | 4,152,100 | Jan 05, 2024, 04:13 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Dec 29, 2023 | Buy | $12.49 | 6,013 | 75,102 | 4,092,731 | Dec 29, 2023, 06:44 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Dec 28, 2023 | Buy | $12.50 | 471,490 | 5,893,625 | 4,086,718 | Dec 29, 2023, 06:44 PM |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | Dec 27, 2023 | Buy | $11.97 | 41,514 | 496,923 | 3,615,228 | Dec 29, 2023, 06:44 PM |
| Crockett Thomas Andrew | CEO | Dec 27, 2023 | Sale | $12.02 | 30,000 | 360,453 | 127,532 | Dec 28, 2023, 04:28 PM |
| Audhya Paul K. | Chief Medical Officer | Nov 20, 2023 | Sale | $8.23 | 7,985 | 65,711 | 36,568 | Nov 21, 2023, 04:34 PM |
| Feener Edward P. | Chief Scientific Officer | Nov 20, 2023 | Sale | $8.23 | 4,958 | 40,801 | 79,828 | Nov 21, 2023, 04:33 PM |
| Yea Christopher | Chief Development Officer | Nov 20, 2023 | Sale | $8.23 | 7,113 | 58,535 | 46,046 | Nov 21, 2023, 04:32 PM |
| Palleiko Benjamin L | President, CFO, CBO & Sec'y | Nov 20, 2023 | Sale | $8.23 | 13,008 | 107,047 | 112,443 | Nov 21, 2023, 04:31 PM |
| Crockett Thomas Andrew | CEO | Nov 20, 2023 | Sale | $8.23 | 14,807 | 121,851 | 157,532 | Nov 21, 2023, 04:30 PM |
| Cha Albert | Director | Sep 11, 2023 | Option Exercise | $7.49 | 18,000 | 134,820 | 18,000 | Sep 13, 2023, 04:29 PM |
| Cha Albert | Director | Sep 11, 2023 | Sale | $10.50 | 18,000 | 189,050 | 0 | Sep 13, 2023, 04:29 PM |
| Audhya Paul K. | Chief Medical Officer | Aug 18, 2023 | Sale | $10.73 | 8,020 | 86,045 | 26,023 | Aug 21, 2023, 08:09 PM |
| Feener Edward P. | Chief Scientific Officer | Aug 18, 2023 | Sale | $10.73 | 4,976 | 53,386 | 73,289 | Aug 21, 2023, 08:07 PM |
| Yea Christopher | Chief Development Officer | Aug 18, 2023 | Sale | $10.73 | 7,142 | 76,624 | 41,662 | Aug 21, 2023, 08:06 PM |
| Palleiko Benjamin L | President, CFO, CBO & Sec'y | Aug 18, 2023 | Sale | $10.73 | 13,067 | 140,192 | 95,254 | Aug 21, 2023, 08:05 PM |
| Crockett Thomas Andrew | CEO | Aug 18, 2023 | Sale | $10.73 | 14,876 | 159,602 | 146,756 | Aug 21, 2023, 08:05 PM |
| Yea Christopher | Chief Development Officer | May 18, 2023 | Sale | $10.14 | 2,604 | 26,416 | 37,310 | May 19, 2023, 09:20 PM |
| Palleiko Benjamin L | President, CFO, CBO & Sec'y | May 18, 2023 | Sale | $10.14 | 4,037 | 40,953 | 78,126 | May 19, 2023, 09:19 PM |
| Feener Edward P. | Chief Scientific Officer | May 18, 2023 | Sale | $10.14 | 1,786 | 18,118 | 66,771 | May 19, 2023, 09:18 PM |
| Crockett Thomas Andrew | CEO | May 18, 2023 | Sale | $10.14 | 5,627 | 57,083 | 128,050 | May 19, 2023, 09:17 PM |
| Audhya Paul K. | Chief Medical Officer | May 18, 2023 | Sale | $10.14 | 2,780 | 28,201 | 13,014 | May 19, 2023, 09:16 PM |
| Audhya Paul K. | Chief Medical Officer | Feb 17, 2023 | Sale | $7.66 | 3,412 | 26,136 | 9,347 | Feb 23, 2023, 05:44 PM |
| Feener Edward P. | Chief Scientific Officer | Feb 17, 2023 | Sale | $7.66 | 2,228 | 17,066 | 64,352 | Feb 23, 2023, 05:44 PM |
| Yea Christopher | Chief Development Officer | Feb 17, 2023 | Sale | $7.66 | 2,727 | 20,889 | 35,709 | Feb 23, 2023, 05:42 PM |
| Palleiko Benjamin L | President, CFO, CBO & Sec'y | Feb 17, 2023 | Sale | $7.66 | 4,954 | 37,948 | 72,799 | Feb 23, 2023, 05:41 PM |
| Crockett Thomas Andrew | CEO | Feb 17, 2023 | Sale | $7.66 | 6,700 | 51,322 | 120,927 | Feb 23, 2023, 05:40 PM |
| Yea Christopher | Chief Development Officer | Nov 18, 2022 | Sale | $5.44 | 1,139 | 6,196 | 34,232 | Nov 21, 2022, 04:21 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Nov 18, 2022 | Sale | $5.44 | 722 | 3,928 | 68,390 | Nov 21, 2022, 04:20 PM |
| Feener Edward P. | Chief Scientific Officer | Nov 18, 2022 | Sale | $5.44 | 530 | 2,883 | 62,376 | Nov 21, 2022, 04:18 PM |
| Crockett Thomas Andrew | CEO | Nov 18, 2022 | Sale | $5.44 | 1,785 | 9,710 | 114,878 | Nov 21, 2022, 04:17 PM |
| Audhya Paul K. | Chief Medical Officer | Nov 18, 2022 | Sale | $5.44 | 722 | 3,928 | 5,946 | Nov 21, 2022, 04:15 PM |
| Crockett Thomas Andrew | CEO | Sep 02, 2022 | Sale | $17.01 | 1,320 | 22,458 | 110,858 | Sep 07, 2022, 04:50 PM |
| Audhya Paul K. | Chief Medical Officer | Aug 17, 2022 | Sale | $14.96 | 725 | 10,847 | 1,693 | Aug 19, 2022, 05:24 PM |
| Feener Edward P. | Chief Scientific Officer | Aug 17, 2022 | Sale | $14.96 | 532 | 7,960 | 61,132 | Aug 19, 2022, 05:17 PM |
| Yea Christopher | Chief Development Officer | Aug 17, 2022 | Sale | $14.96 | 1,145 | 17,130 | 33,597 | Aug 19, 2022, 05:16 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Aug 17, 2022 | Sale | $14.96 | 725 | 10,847 | 66,693 | Aug 19, 2022, 05:15 PM |
| Crockett Thomas Andrew | CEO | Aug 17, 2022 | Sale | $14.96 | 1,797 | 26,890 | 112,178 | Aug 19, 2022, 04:58 PM |
| Crockett Thomas Andrew | CEO | Mar 09, 2022 | Sale | $17.07 | 10,000 | 170,693 | 114,670 | Mar 11, 2022, 04:56 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 07, 2022 | Option Exercise | $7.54 | 57,657 | 434,832 | 59,891 | Jan 11, 2022, 04:42 PM |
| Feener Edward P. | Chief Scientific Officer | Nov 01, 2021 | Sale | $18.07 | 6,000 | 108,424 | 2,234 | Nov 03, 2021, 05:00 PM |
| Yea Christopher | Chief Development Officer | Nov 01, 2021 | Sale | $18.07 | 5,000 | 90,328 | 32,969 | Nov 03, 2021, 04:56 PM |
| Crockett Thomas Andrew | CEO | Oct 01, 2021 | Sale | $17.18 | 10,000 | 171,841 | 124,670 | Oct 04, 2021, 04:57 PM |
| Yea Christopher | Chief Development Officer | Aug 02, 2021 | Sale | $20.52 | 5,000 | 102,578 | 37,969 | Aug 04, 2021, 07:55 PM |
| Feener Edward P. | Chief Scientific Officer | Aug 02, 2021 | Sale | $20.52 | 6,000 | 123,134 | 8,234 | Aug 04, 2021, 07:55 PM |
| Crockett Thomas Andrew | CEO | Jul 01, 2021 | Sale | $24.15 | 10,000 | 241,477 | 140,320 | Jul 02, 2021, 05:35 PM |
| Crockett Thomas Andrew | CEO | Jun 09, 2021 | Sale | $30.05 | 8,933 | 268,480 | 145,737 | Jun 11, 2021, 07:29 PM |
| Smith Michael David | Senior VP, Development | Jun 01, 2021 | Option Exercise | $8.39 | 7,500 | 62,925 | 7,500 | Jun 03, 2021, 06:28 PM |
| Smith Michael David | Senior VP, Development | Jun 01, 2021 | Sale | $26.83 | 7,500 | 201,221 | 0 | Jun 03, 2021, 06:28 PM |
| Feener Edward P. | Chief Scientific Officer | Jun 02, 2021 | Sale | $26.43 | 8,200 | 216,696 | 15,296 | Jun 03, 2021, 06:26 PM |
| Feener Edward P. | Chief Scientific Officer | Jun 01, 2021 | Sale | $26.81 | 25,800 | 691,665 | 22,448 | Jun 03, 2021, 06:26 PM |
| Feener Edward P. | Chief Scientific Officer | May 03, 2021 | Option Exercise | $10.21 | 6,000 | 61,260 | 60,234 | May 06, 2021, 08:03 PM |
| Feener Edward P. | Chief Scientific Officer | May 03, 2021 | Sale | $24.84 | 6,000 | 149,051 | 54,234 | May 06, 2021, 08:03 PM |
| Smith Michael David | Senior VP, Development | Apr 28, 2021 | Option Exercise | $8.39 | 10,014 | 84,017 | 10,014 | Apr 30, 2021, 05:49 PM |
| Smith Michael David | Senior VP, Development | Apr 28, 2021 | Sale | $25.76 | 10,014 | 257,983 | 0 | Apr 30, 2021, 05:49 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 28, 2021 | Option Exercise | $7.91 | 36,127 | 285,765 | 36,127 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 27, 2021 | Option Exercise | $7.91 | 11,017 | 87,144 | 11,017 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 29, 2021 | Option Exercise | $10.69 | 40,886 | 437,023 | 40,886 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 28, 2021 | Sale | $25.41 | 36,127 | 917,985 | 25,507 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 27, 2021 | Sale | $25.79 | 11,017 | 284,163 | 0 | Apr 29, 2021, 08:55 PM |
| Maetzel Andreas | Senior Vice President, Medical | Apr 29, 2021 | Sale | $25.04 | 40,886 | 1,023,589 | 0 | Apr 29, 2021, 08:55 PM |
| Crockett Thomas Andrew | CEO | Apr 01, 2021 | Sale | $27.44 | 10,000 | 274,436 | 168,720 | Apr 05, 2021, 06:38 PM |
| Yea Christopher | Chief Development Officer | Feb 23, 2021 | Sale | $33.59 | 15,000 | 503,877 | 62,169 | Feb 25, 2021, 08:25 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Feb 23, 2021 | Option Exercise | $6.74 | 29,642 | 199,787 | 94,642 | Feb 25, 2021, 08:23 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Feb 23, 2021 | Sale | $33.59 | 29,642 | 995,562 | 93,642 | Feb 25, 2021, 08:23 PM |
| Feener Edward P. | Chief Scientific Officer | Feb 23, 2021 | Sale | $33.60 | 31,000 | 1,041,642 | 83,946 | Feb 25, 2021, 08:22 PM |
| Crockett Thomas Andrew | CEO | Feb 23, 2021 | Sale | $33.55 | 10,000 | 335,538 | 178,920 | Feb 25, 2021, 08:20 PM |
| Crockett Thomas Andrew | CEO | Jan 04, 2021 | Sale | $18.19 | 10,000 | 181,904 | 186,234 | Jan 06, 2021, 05:33 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Dec 30, 2020 | Option Exercise | $6.74 | 358 | 2,413 | 32,858 | Jan 04, 2021, 06:06 PM |
| Palleiko Benjamin L | CFO, CBO & Secretary | Dec 30, 2020 | Sale | $20.04 | 358 | 7,175 | 32,500 | Jan 04, 2021, 06:06 PM |
| Feener Edward P. | Chief Scientific Officer | Nov 02, 2020 | Sale | $17.14 | 6,000 | 102,812 | 72,734 | Nov 04, 2020, 05:03 PM |
| Cha Albert | Director | Oct 30, 2020 | Buy | $17.24 | 115,686 | 1,994,068 | 1,138,179 | Nov 03, 2020, 07:56 PM |
| Yea Christopher | Chief Development Officer | Oct 29, 2020 | Sale | $17.48 | 5,000 | 87,394 | 62,969 | Nov 02, 2020, 08:01 PM |
| Yea Christopher | Chief Development Officer | Oct 21, 2020 | Sale | $18.25 | 6,044 | 110,282 | 70,513 | Oct 22, 2020, 05:36 PM |
| Yea Christopher | Chief Development Officer | Oct 20, 2020 | Sale | $17.49 | 7,942 | 138,886 | 76,315 | Oct 22, 2020, 05:36 PM |
| Feener Edward P. | Chief Scientific Officer | Oct 21, 2020 | Sale | $18.31 | 9,007 | 164,928 | 84,141 | Oct 22, 2020, 05:34 PM |
| Feener Edward P. | Chief Scientific Officer | Oct 20, 2020 | Sale | $17.48 | 7,900 | 138,090 | 90,041 | Oct 22, 2020, 05:34 PM |
| Crockett Thomas Andrew | CEO | Oct 21, 2020 | Sale | $18.33 | 22,545 | 413,247 | 212,165 | Oct 22, 2020, 05:33 PM |
| Crockett Thomas Andrew | CEO | Oct 20, 2020 | Sale | $17.49 | 15,994 | 279,778 | 222,741 | Oct 22, 2020, 05:33 PM |
| Yea Christopher | Chief Development Officer | Oct 16, 2020 | Sale | $17.00 | 914 | 15,539 | 81,955 | Oct 20, 2020, 02:14 PM |
| Feener Edward P. | Chief Scientific Officer | Oct 16, 2020 | Sale | $17.00 | 993 | 16,881 | 95,641 | Oct 20, 2020, 02:11 PM |
| Crockett Thomas Andrew | CEO | Oct 16, 2020 | Sale | $17.01 | 1,261 | 21,444 | 236,959 | Oct 20, 2020, 02:08 PM |
| Yea Christopher | Chief Development Officer | Feb 05, 2020 | Sale | $17.10 | 100 | 1,710 | 82,869 | Feb 07, 2020, 05:18 PM |
| Feener Edward P. | Chief Scientific Officer | Feb 05, 2020 | Sale | $17.11 | 100 | 1,711 | 96,634 | Feb 07, 2020, 05:17 PM |
| Crockett Thomas Andrew | CEO | Feb 05, 2020 | Sale | $17.05 | 200 | 3,410 | 238,220 | Feb 07, 2020, 05:14 PM |
| Yea Christopher | Chief Development Officer | Dec 20, 2019 | Option Exercise | $0.00 | 2,646 | 11 | 85,615 | Dec 26, 2019, 05:32 PM |
| Yea Christopher | Chief Development Officer | Dec 20, 2019 | Sale | $17.02 | 2,646 | 45,025 | 82,969 | Dec 26, 2019, 05:32 PM |
| Crockett Thomas Andrew | CEO | Dec 20, 2019 | Sale | $17.02 | 2,300 | 39,150 | 238,420 | Dec 26, 2019, 05:30 PM |
| Yea Christopher | Chief Development Officer | Dec 13, 2019 | Option Exercise | $0.00 | 1,500 | 6 | 84,469 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 12, 2019 | Option Exercise | $0.00 | 199 | 1 | 83,168 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 16, 2019 | Option Exercise | $0.00 | 3,010 | 13 | 85,979 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 13, 2019 | Sale | $17.05 | 1,500 | 25,568 | 82,969 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 12, 2019 | Sale | $17.00 | 199 | 3,383 | 82,969 | Dec 16, 2019, 07:34 PM |
| Yea Christopher | Chief Development Officer | Dec 16, 2019 | Sale | $17.05 | 3,010 | 51,318 | 82,969 | Dec 16, 2019, 07:34 PM |
| Crockett Thomas Andrew | CEO | Dec 12, 2019 | Sale | $17.00 | 100 | 1,700 | 248,320 | Dec 16, 2019, 07:32 PM |
| Crockett Thomas Andrew | CEO | Dec 16, 2019 | Sale | $17.06 | 5,400 | 92,116 | 240,720 | Dec 16, 2019, 07:32 PM |
| Crockett Thomas Andrew | CEO | Dec 13, 2019 | Sale | $17.06 | 2,200 | 37,536 | 246,120 | Dec 16, 2019, 07:32 PM |
| SOLAND DANIEL B | Director | Sep 27, 2019 | Buy | $11.87 | 7,962 | 94,498 | 10,000 | Sep 30, 2019, 05:23 PM |
| SOLAND DANIEL B | Director | Sep 26, 2019 | Buy | $11.90 | 2,038 | 24,252 | 2,038 | Sep 30, 2019, 05:23 PM |
| Cha Albert | Director | Jul 29, 2019 | Buy | $17.13 | 5,137 | 88,011 | 124,566 | Jul 30, 2019, 07:37 PM |
| Cha Albert | Director | Jul 29, 2019 | Buy | $17.13 | 24,730 | 423,692 | 1,022,493 | Jul 30, 2019, 07:37 PM |
| Cha Albert | Director | Jul 26, 2019 | Buy | $16.83 | 21,942 | 369,317 | 997,763 | Jul 30, 2019, 07:37 PM |
| Cha Albert | Director | Jul 26, 2019 | Buy | $16.83 | 4,558 | 76,718 | 119,429 | Jul 30, 2019, 07:37 PM |
| Yea Christopher | Chief Development Officer | Jul 22, 2019 | Option Exercise | $0.00 | 7,355 | 32 | 90,324 | Jul 24, 2019, 05:53 PM |
| Yea Christopher | Chief Development Officer | Jul 22, 2019 | Sale | $18.35 | 7,355 | 134,930 | 82,969 | Jul 24, 2019, 05:53 PM |
| Feener Edward P. | Chief Scientific Officer | Jul 23, 2019 | Sale | $18.65 | 1,900 | 35,439 | 96,734 | Jul 24, 2019, 05:52 PM |
| Feener Edward P. | Chief Scientific Officer | Jul 22, 2019 | Sale | $18.57 | 1,400 | 26,004 | 98,634 | Jul 24, 2019, 05:52 PM |
| Cha Albert | Director | Jul 17, 2019 | Buy | $16.93 | 220 | 3,724 | 104,551 | Jul 19, 2019, 06:38 PM |
| Cha Albert | Director | Jul 17, 2019 | Buy | $16.97 | 1,060 | 17,991 | 926,141 | Jul 19, 2019, 06:38 PM |
| Cha Albert | Director | Jul 19, 2019 | Buy | $17.84 | 49,680 | 886,127 | 975,821 | Jul 19, 2019, 06:38 PM |
| Cha Albert | Director | Jul 19, 2019 | Buy | $17.68 | 10,320 | 182,453 | 114,871 | Jul 19, 2019, 06:38 PM |
| Crockett Thomas Andrew | CEO | Jul 15, 2019 | Sale | $17.04 | 10,000 | 170,407 | 248,510 | Jul 17, 2019, 06:52 PM |
| Yea Christopher | Chief Development Officer | Apr 22, 2019 | Option Exercise | $0.00 | 7,355 | 32 | 90,324 | Apr 23, 2019, 05:33 PM |
| Yea Christopher | Chief Development Officer | Apr 22, 2019 | Sale | $26.04 | 7,355 | 191,530 | 83,969 | Apr 23, 2019, 05:33 PM |
| Crockett Thomas Andrew | CEO | Apr 15, 2019 | Sale | $24.80 | 10,000 | 247,958 | 258,810 | Apr 23, 2019, 05:30 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 22, 2019 | Option Exercise | $8.39 | 2,000 | 16,780 | 34,500 | Apr 22, 2019, 05:58 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 18, 2019 | Option Exercise | $6.74 | 1,073 | 7,232 | 33,573 | Apr 22, 2019, 05:58 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 18, 2019 | Sale | $25.51 | 1,073 | 27,373 | 32,500 | Apr 22, 2019, 05:58 PM |
| Palleiko Benjamin L | CBO, CFO and Secretary | Apr 22, 2019 | Sale | $25.80 | 2,000 | 51,603 | 32,500 | Apr 22, 2019, 05:58 PM |
| Feener Edward P. | Chief Scientific Officer | Apr 17, 2019 | Sale | $24.92 | 4,000 | 99,666 | 100,950 | Apr 18, 2019, 06:30 PM |
| SVLSF IV, LLC | 10% Owner | Apr 10, 2019 | Sale | $29.40 | 13,531 | 397,746 | 1,672,105 | Apr 10, 2019, 07:21 PM |
| SVLSF IV, LLC | 10% Owner | Apr 08, 2019 | Sale | $29.49 | 22,800 | 672,415 | 1,698,554 | Apr 10, 2019, 07:21 PM |
| SVLSF IV, LLC | 10% Owner | Apr 09, 2019 | Sale | $28.53 | 13,669 | 389,983 | 1,685,262 | Apr 10, 2019, 07:21 PM |
| Maetzel Andreas | Senior Vice President Medical | Apr 05, 2019 | Option Exercise | $7.91 | 5,000 | 39,550 | 5,000 | Apr 09, 2019, 05:33 PM |
| Maetzel Andreas | Senior Vice President Medical | Apr 05, 2019 | Sale | $30.00 | 5,000 | 150,011 | 0 | Apr 09, 2019, 05:33 PM |
| SVLSF IV, LLC | 10% Owner | Apr 02, 2019 | Sale | $28.76 | 9,141 | 262,930 | 1,720,725 | Apr 02, 2019, 06:57 PM |
| SVLSF IV, LLC | 10% Owner | Apr 01, 2019 | Sale | $27.66 | 52,831 | 1,461,210 | 1,729,613 | Apr 02, 2019, 06:57 PM |
| SVLSF IV, LLC | 10% Owner | Mar 29, 2019 | Sale | $28.40 | 35,102 | 996,756 | 1,780,986 | Apr 02, 2019, 06:57 PM |
| SVLSF IV, LLC | 10% Owner | Mar 26, 2019 | Sale | $29.70 | 30,093 | 893,687 | 1,907,090 | Mar 28, 2019, 05:29 PM |
| SVLSF IV, LLC | 10% Owner | Mar 28, 2019 | Sale | $27.80 | 36,665 | 1,019,324 | 1,815,119 | Mar 28, 2019, 05:29 PM |
| SVLSF IV, LLC | 10% Owner | Mar 27, 2019 | Sale | $29.06 | 57,917 | 1,683,022 | 1,850,772 | Mar 28, 2019, 05:29 PM |
| SVLSF IV, LLC | 10% Owner | Mar 18, 2019 | Sale | $26.70 | 262,470 | 7,007,949 | 1,936,352 | Mar 20, 2019, 04:13 PM |
| Venrock Healthcare Capital Partners II, L.P. | 10% Owner | Mar 18, 2019 | Sale | $28.75 | 500,000 | 14,375,000 | 1,544,112 | Mar 20, 2019, 04:08 PM |
| Crockett Thomas Andrew | CEO | Mar 14, 2019 | Sale | $30.16 | 3,000 | 90,484 | 268,510 | Mar 15, 2019, 08:03 PM |
| SVLSF IV, LLC | 10% Owner | Mar 05, 2019 | Sale | $23.04 | 32,332 | 744,816 | 2,191,576 | Mar 06, 2019, 09:05 AM |
| SVLSF IV, LLC | 10% Owner | Mar 04, 2019 | Sale | $22.91 | 43,378 | 993,660 | 2,223,015 | Mar 06, 2019, 09:05 AM |
| SVLSF IV, LLC | 10% Owner | Feb 21, 2019 | Sale | $20.60 | 172,543 | 3,554,386 | 2,265,196 | Feb 21, 2019, 02:35 PM |
| SVLSF IV, LLC | 10% Owner | Feb 20, 2019 | Sale | $20.02 | 23,235 | 465,069 | 2,432,975 | Feb 21, 2019, 02:35 PM |
| SVLSF IV, LLC | 10% Owner | Feb 19, 2019 | Sale | $20.73 | 18,420 | 381,898 | 2,455,569 | Feb 21, 2019, 02:35 PM |
| Yea Christopher | Chief Development Officer | Jan 25, 2019 | Option Exercise | $0.00 | 5,453 | 23 | 88,422 | Jan 29, 2019, 06:53 PM |
| Yea Christopher | Chief Development Officer | Jan 25, 2019 | Sale | $17.06 | 5,453 | 93,015 | 82,969 | Jan 29, 2019, 06:53 PM |
| Yea Christopher | Chief Development Officer | Jan 22, 2019 | Option Exercise | $0.00 | 1,302 | 6 | 84,271 | Jan 24, 2019, 07:48 PM |
| Yea Christopher | Chief Development Officer | Jan 23, 2019 | Option Exercise | $0.00 | 600 | 3 | 83,569 | Jan 24, 2019, 07:48 PM |
| Yea Christopher | Chief Development Officer | Jan 22, 2019 | Sale | $17.00 | 1,302 | 22,139 | 82,969 | Jan 24, 2019, 07:48 PM |
| Yea Christopher | Chief Development Officer | Jan 23, 2019 | Sale | $17.01 | 600 | 10,205 | 82,969 | Jan 24, 2019, 07:48 PM |
| Feener Edward P. | Chief Scientific Officer | Jan 16, 2019 | Sale | $19.55 | 4,000 | 78,210 | 106,334 | Jan 18, 2019, 05:42 PM |
| Crockett Thomas Andrew | CEO | Jan 14, 2019 | Sale | $19.33 | 10,000 | 193,328 | 272,411 | Jan 16, 2019, 06:25 PM |
| SVLSF IV, LLC | 10% Owner | Jan 07, 2019 | Sale | $20.41 | 2,599 | 53,051 | 2,473,481 | Jan 07, 2019, 05:12 PM |
| SVLSF IV, LLC | 10% Owner | Jan 03, 2019 | Sale | $20.01 | 1,700 | 34,022 | 2,476,008 | Jan 07, 2019, 05:12 PM |
| SVLSF IV, LLC | 10% Owner | Jan 02, 2019 | Sale | $20.00 | 200 | 4,000 | 2,477,661 | Jan 02, 2019, 07:10 PM |
| SVLSF IV, LLC | 10% Owner | Dec 31, 2018 | Sale | $20.00 | 25,418 | 508,462 | 2,477,855 | Jan 02, 2019, 07:10 PM |
| SVLSF IV, LLC | 10% Owner | Dec 28, 2018 | Sale | $20.03 | 3,734 | 74,781 | 2,502,571 | Jan 02, 2019, 07:10 PM |
| SVLSF IV, LLC | 10% Owner | Dec 19, 2018 | Sale | $20.02 | 2,136 | 42,758 | 2,506,202 | Dec 21, 2018, 04:19 PM |
| Feener Edward P. | Chief Scientific Officer | Sep 18, 2018 | Option Exercise | $17.05 | 2,500 | 42,625 | 108,034 | Sep 20, 2018, 07:33 PM |
| ORONSKY ARNOLD L | Director | Sep 10, 2018 | Buy | $17.00 | 58,824 | 1,000,008 | 388,766 | Sep 12, 2018, 12:00 AM |
| Cha Albert | Director | Sep 10, 2018 | Buy | $17.00 | 1,058,824 | 18,000,008 | 1,359,149 | Sep 12, 2018, 12:00 AM |
| ALDRICH RICHARD | Director | Oct 12, 2017 | Buy | $8.61 | 565,065 | 4,866,961 | 934,484 | Oct 19, 2017, 08:29 PM |
| RA CAPITAL MANAGEMENT, LLC | Director | Oct 12, 2017 | Buy | $8.50 | 850,000 | 7,225,000 | 1,441,070 | Oct 16, 2017, 04:32 PM |
| Shah Rajeev M. | Director | Oct 12, 2017 | Buy | $8.50 | 850,000 | 7,225,000 | 1,441,070 | Oct 16, 2017, 04:31 PM |
| Novo Holdings A/S | 10% Owner | Oct 12, 2017 | Sale | $8.50 | 1,726,481 | 14,675,820 | 1,726,000 | Oct 12, 2017, 05:21 PM |
| Novo Holdings A/S | 10% Owner | Oct 11, 2017 | Sale | $10.21 | 35,519 | 362,763 | 1,726,481 | Oct 12, 2017, 05:21 PM |
| Novo Holdings A/S | 10% Owner | Oct 10, 2017 | Sale | $11.66 | 963,283 | 11,232,599 | 2,311,927 | Oct 12, 2017, 05:21 PM |
| Novo Holdings A/S | 10% Owner | Sep 15, 2017 | Sale | $7.00 | 140,744 | 985,841 | 2,725,283 | Sep 18, 2017, 07:04 PM |
| Novo Holdings A/S | 10% Owner | Sep 14, 2017 | Sale | $8.05 | 10,000 | 80,500 | 2,866,027 | Sep 18, 2017, 07:04 PM |
| Novo Holdings A/S | 10% Owner | Sep 13, 2017 | Sale | $8.02 | 25,900 | 207,614 | 2,876,027 | Sep 18, 2017, 07:04 PM |
| Novo Holdings A/S | 10% Owner | Sep 15, 2017 | Sale | $7.00 | 140,747 | 985,865 | 2,725,283 | Sep 15, 2017, 07:18 PM |
| Novo Holdings A/S | 10% Owner | Sep 14, 2017 | Sale | $8.05 | 10,000 | 80,500 | 2,866,027 | Sep 15, 2017, 07:18 PM |
| Novo Holdings A/S | 10% Owner | Sep 13, 2017 | Sale | $8.02 | 25,900 | 207,614 | 2,876,027 | Sep 15, 2017, 07:18 PM |
| Renzi David | President & CEO | Nov 21, 2016 | Option Exercise | $8.59 | 33,454 | 287,477 | 3,186 | Nov 23, 2016, 01:35 PM |
| Renzi David | President & CEO | Nov 21, 2016 | Option Exercise | $7.84 | 36,640 | 287,258 | 36,640 | Nov 23, 2016, 01:35 PM |
| Renzi David | President & CEO | Nov 21, 2016 | Option Exercise | $8.59 | 3,186 | 27,378 | 0 | Nov 23, 2016, 01:35 PM |
| Basta Steven L | Director | Nov 21, 2016 | Option Exercise | $8.59 | 1,026 | 8,817 | 99 | Nov 22, 2016, 04:14 PM |
| Basta Steven L | Director | Nov 21, 2016 | Option Exercise | $7.84 | 1,125 | 8,820 | 1,125 | Nov 22, 2016, 04:14 PM |
| Basta Steven L | Director | Nov 21, 2016 | Option Exercise | $8.59 | 99 | 851 | 0 | Nov 22, 2016, 04:14 PM |
| Maroney Marcee | VP, Clinical Affairs | Nov 21, 2016 | Option Exercise | $8.59 | 4,255 | 36,564 | 409 | Nov 22, 2016, 04:13 PM |
| Maroney Marcee | VP, Clinical Affairs | Nov 21, 2016 | Option Exercise | $7.84 | 4,664 | 36,566 | 4,664 | Nov 22, 2016, 04:13 PM |
| Maroney Marcee | VP, Clinical Affairs | Nov 21, 2016 | Option Exercise | $8.59 | 409 | 3,515 | 0 | Nov 22, 2016, 04:13 PM |
| Renzi David | President & CEO | Dec 30, 2015 | Option Exercise | $0.56 | 10,000 | 5,600 | 10,000 | Dec 31, 2015, 04:05 PM |
| Renzi David | President & CEO | Dec 30, 2015 | Sale | $3.70 | 10,000 | 37,000 | 0 | Dec 31, 2015, 04:05 PM |
| CHA ALBERT | Director | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,562 | Apr 27, 2015, 02:40 PM |
| Vivo Ventures VI, LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,562 | Apr 24, 2015, 07:03 PM |
| InterWest Management Partners IX, LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 810,000 | 4,050,000 | 4,619,196 | Apr 14, 2015, 05:26 PM |
| ACMP IV LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 877,500 | 4,387,500 | 4,343,550 | Apr 14, 2015, 05:24 PM |
| NOHRA GUY P | Director | Apr 14, 2015 | Buy | $5.00 | 877,500 | 4,387,500 | 4,343,550 | Apr 14, 2015, 05:22 PM |
| CHA ALBERT | Director | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,564 | Apr 14, 2015, 05:22 PM |
| Vivo Ventures VI, LLC | 10% Owner | Apr 14, 2015 | Buy | $5.00 | 1,012,500 | 5,062,500 | 4,204,564 | Apr 14, 2015, 05:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN KALVISTA PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,684,005 | 1.49% | 10.87% | Growth At A Reasonable Price |
| BLACKROCK INC. | 2,242,025 | 0.0007% | 36.31% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,028,568 | 0.15% | -0.59% | Growth |
| VIVO CAPITAL, LLC | 856,008 | 0.86% | No change | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,845,000 | 0.10% | 303.55% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 630,048 | 0.00081% | 20.72% | Other |
| D. E. SHAW & CO., INC. | 88,763 | 0.00095% | -23% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 42,300 | 0.0008% | -38.78% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 11,905 | 0.00027% | 11.57% | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR KALVISTA PHARMACEUTICALS INC
STOCK BUYBACKS FOR KALVISTA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 01/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
10/31/2023
0.46%
1Q
07/31/2023
0.90%
2Q
04/30/2023
24.50%
3Q
01/31/2023
22.79%
4Q
10/31/2022
41.18%
5Q
07/31/2022
41.40%
6Q
04/30/2022
41.48%
7Q
01/31/2022
41.85%
8Q
10/31/2021
42.08%
9Q
07/31/2021
42.13%
10Q
04/30/2021
53.24%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR KALVISTA PHARMACEUTICALS INC
LOADING...